HLA-G, pre-eclampsia, immunity and vascular events

被引:68
作者
Le Bouteiller, P [1 ]
Pizzato, N [1 ]
Barakonyi, A [1 ]
Solier, C [1 ]
机构
[1] Hop Purpan, INSERM, U563, Ctr Physiopathol Toulouse Purpan, F-31059 Toulouse 3, France
关键词
HLA-G; placenta; apoptosis; NK cells; cytomegalovirus; endothelial cells;
D O I
10.1016/S0165-0378(03)00049-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pre-eclampsia, one of the main complications in pregnancy, is characterised by shallow cytotrophoblast invasion of decidua as well as by vascular endothelial cell dysfunction, leading to a poor perfusion of placenta. A striking feature of pre-eclamptic pregnancies is that expression of HLA-G protein is reduced in term placentas compared with normal pregnancy. How such HLA-G deficient expression may be related to the pre-eclamptic pathology is unknown. Here, we review the major structural characteristics of HLA-G and some of its functions that have been recently characterised. Soluble HLA-G1 isoform down-regulates both CD8(+) and CD4(+) T cell reactivity. H LA-G also modulates innate immunity by binding to several NK and/or decidual receptors, inducing particular cytokine secretion. HLA-G was shown to be less susceptible to human cytomegalovirus-derived US protein down-modulation. Finally, soluble HLA-G1 down-regulates endothelial cell proliferation and migration. In view of these different HLA-G properties, we will briefly discuss how defective HLA-G function may contribute to the low trophoblast invasion and vascular abnormalities observed in pre-eclamptic placentas. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:219 / 234
页数:16
相关论文
共 90 条
[1]   Interferon γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy [J].
Ashkar, AA ;
Di Santo, JP ;
Croy, BA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) :259-269
[2]   Characteristics of the fetal/maternal interface with potential usefulness in the development of future immunological and pharmacological strategies [J].
Audus, KL ;
Soares, MJ ;
Hunt, JS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02) :402-409
[3]  
Avril T, 1999, J IMMUNOL, V162, P5902
[4]   HLA-G remains a mystery [J].
Bainbridge, D ;
Ellis, S ;
Le Bouteiller, P ;
Sargent, I .
TRENDS IN IMMUNOLOGY, 2001, 22 (10) :548-552
[5]   HLA-G suppresses proliferation of CD4+ T-lymphocytes [J].
Bainbridge, DRJ ;
Ellis, SA ;
Sargent, IL .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 48 (01) :17-26
[6]   Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G [J].
Blaschitz, A ;
Lenfant, F ;
Mallet, V ;
Hartmann, M ;
Bensussan, A ;
Geraghty, DE ;
Le Bouteiller, P ;
Dohr, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3380-3388
[7]  
BOYSON JE, 2002, P NATL ACAD SCI USA, V26, P26
[8]  
Cantoni C, 1998, EUR J IMMUNOL, V28, P1980, DOI 10.1002/(SICI)1521-4141(199806)28:06<1980::AID-IMMU1980>3.0.CO
[9]  
2-F
[10]   Preeclampsia: A multifactorial disease resulting from the interaction of the feto-maternal HLA genotype and HCMV infection [J].
Carreiras, M ;
Montagnani, S ;
Layrisse, Z .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2002, 48 (03) :176-183